Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulva
Bernadette Cracchiolo(Rutgers, The State University of New Jersey), Hartmut M. Hanauske‐Abel(National Institutes of Health), Paul M. Clément(Universitair Ziekenhuis Leuven), Myung‐Hee Park(National Institutes of Health), Edith C. Wolff(National Institutes of Health), Debra S. Heller(Rutgers, The State University of New Jersey)
Cited by 49
Related Papers
The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology
|Archives of Pathology & Laboratory Medicine|2012|999
Lomustine and Bevacizumab in Progressive Glioblastoma
|New England Journal of Medicine|2017|994
Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
|Journal of Clinical Oncology|2009|573
The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated Lesions
|International Journal of Gynecological Pathology|2012|568